XtalPi Names CFO

MT Newswires Live03-10

Pharmaceutical research firm XtalPi (HKG:2228) appointed Zhou Feiran as its CFO effective Tuesday, according to a same-day Hong Kong bourse filing.

Zhou worked at J.P. Morgan from 2020 to 2026, with his last position being an executive Director in the Global Healthcare Investment Banking division.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment